Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer
/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers from...
Stay updated with breaking news from Second Genome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers from...
Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer - read this article along with other careers information, tips and advice on BioSpace
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Human Microbiome Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been...
The global human microbiome market is expected to register a CAGR of nearly 17% over the forecast period. In recent times, the human microbiome has become...
/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform sg-4sight to discover and develop precision therapies and...